Intrigued by the lack of difference in the traditional inflammation parameters, we explored serum levels of other biomarkers which have been associated with an unfavorable outcome of RA with respect to erosivity and response to TNF-inhibitors [19,23,24,25]. This evidence concerns the gene TNF and rheumatoid arthritis.